Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Despite the similar clinical and pathological features between Niemann-Pick type C (NPC) disease and Alzheimer's disease (AD), few studies have investigated the role of NPC genes in AD. To elucidate the role of NPC genes in AD, we sequenced NPC1 and NPC2 in 1192 AD patients and 2412 controls. Variants were divided into common variants and rare variants according to minor allele frequency (MAF). Common variant (MAF≥0.01) based association analysis was conducted by PLINK 1.9. Gene-based aggregation testing of rare variants was performed by Sequence Kernel Association Test-Optimal (SKAT-O test), respectively. Age at onset (AAO) and mini-mental state examination (MMSE) association studies were also performed with PLINK 1.9. Six common variants were identified and exhibited no association with AD. Gene-based aggregation testing revealed that both NPC1 and NPC2 were not associated with AD risk. Additionally, AAO and MMSE association studies revealed that no common variants were linked with AD endophenotypes. Taken together, our study indicated that NPC1 and NPC2 may not be implicated in AD pathogenesis in the Chinese population.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.neurobiolaging.2022.04.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Gene Expression Profile of the Cerebral Cortex of Niemann-Pick Disease Type C Mutant Mice.
Genes (Basel)
July 2025
Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Campus Guadalajara, Zapopan 45201, Mexico.
Background/objectives: Niemann-Pick disease Type C (NPC) represents an autosomal recessive disorder with an incidence rate of 1 in 100,000 live births that belongs to the lysosomal storage diseases (LSDs). NPC is characterized by the abnormal accumulation of unesterified cholesterol, in addition to being an autosomal recessive inherited pathology, which belongs to LSDs. It occurs in 95% of cases due to mutations in the NPC1 gene, while 5% of cases are due to mutations in the NPC2 gene.
View Article and Find Full Text PDFHeterozygosity in NPC may be associated with neurologic and systemic phenotypes.
Front Neurol
August 2025
INSPIRE-PNRM+, Neuroimaging Center (NIC), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
Background: Niemann-Pick disease type C (NPC) is a pan-ethnic, progressive, recessively inherited lysosomal disorder that affects 1:100,000 live births. Emerging biochemical, genetic, and clinical evidence challenges the traditional view that disease-associated variants in the genes associated with the typical phenotype NPC manifest as an exclusively autosomal recessive disorder. While biallelic pathogenic variants cause the NPC disease phenotype, heterozygous carriers may exhibit phenotypic traits attributable to a partial loss of or function.
View Article and Find Full Text PDFAdvances in mass spectrometry of lipids for the investigation of Niemann-pick type C disease.
Lipids Health Dis
July 2025
Department of Chemistry, University of Illinois Chicago, Chicago, 60607, IL, USA.
Niemann-Pick type C (NPC) disease is a devastating, fatal, neurodegenerative disease and a form of lysosomal storage disorder. It is caused by mutations in either NPC1 or NPC2 genes, leading to the accumulation of cholesterol and other lipids in the late endosome/lysosome system, a hallmark of the disease. Due to aberrant lipid trafficking in NPC, various techniques have been employed to study cholesterol and lipid dysregulation.
View Article and Find Full Text PDFExploration of Bromodomain Proteins as Drug Targets for Niemann-Pick Type C Disease.
Int J Mol Sci
June 2025
Department of Science, Section Biomedical Science and Technology, University Roma Tre, Viale Marconi 446, 00146 Rome, Italy.
Defects in lysosomal cholesterol handling provoke fatal disorders presenting neurovisceral symptoms with variable onset and life spans. A prime example is Niemann-Pick type C disease (NPCD), where cholesterol export from the endosomal-lysosomal system is impaired due to variants of either NPC intracellular cholesterol transporter 1 (NPC1) or NPC intracellular cholesterol transporter 2 (NPC2). Therapeutic options for NPCD are limited to palliative care and disease-modifying drugs, and there is a need for new treatments.
View Article and Find Full Text PDFA novel approach using a polarized nonius test to evaluate the near point of convergence.
J Optom
July 2025
Centre for Sensors, Instruments and Systems Development (CD6). Universitat Politècnica de Catalunya - BarcelonaTech (UPC). Campus Terrassa. Rambla de Sant Nebridi, 10, 08222 Terrassa, Barcelona, Spain; Departament d'Òptica i Optometria (DOO), Universitat Politècnica de Catalunya (UPC), Campus de
Purpose: This study aims to evaluate the efficacy of a new method for measuring the near point of convergence (NPC) using a Nonius polarized target stimulus, comparing its sensitivity in detecting convergence ability to that of traditional approaches.
Methods: In this prospective study, 65 participants underwent near point of convergence (NPC) measurements using three methods: an accommodative target (NPC1), a penlight with a red filter (NPC2), and a Nonius polarized target (NPC3). Participants also completed the Convergence Insufficiency Symptom Survey (CISS).